3
Announcements
Trials
Browse
Landscape
Status
Completed
2
Sponsor Class
INDUSTRY
2
Study Type
Observational
2
Sponsor
Cancer Type
Genitourinary
3
Plasma cell
2
Breast
2
Sarcoma
1
Conditions
Prostatic Neoplasms
2
Multiple Myeloma
2
Breast Neoplasms
2
Patient Compliance
1
Osteolysis
1
Bone Neoplasms
1
Interventions
Specimen Handling
4
Zoledronic Acid
3
Vorinostat
3
Azacitidine
3
venetoclax
2
trametinib
2
ruxolitinib
2
pertuzumab
2
palbociclib
2
dabrafenib
2
copanlisib
2
abiraterone
2
Sunitinib
2
Sorafenib
2
Oxaliplatin
2
Nivolumab
2
Magnetic Resonance Spectroscopy
2
Leucovorin
2
Immunoglobulin G
2
HhAntag691
2
Fluorouracil
2
Doxorubicin
2
Disulfides
2
Dasatinib
2
Clodronic Acid
2
Bevacizumab
2
Afatinib
2
Ado-Trastuzumab Emtansine
2
2C4 antibody
2
ulixertinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Prostatic Neoplasms
×
Clodronic Acid
×
Plasma cell
×
Clear all
NCT01198457
2012-09-07
BONA
Bayer
Completed
147 enrolled
NCT00909142
2012-04-06
BICAM
Bayer
Completed
149 enrolled